Irazu Oncology
Baltimore
About Irazu Oncology
Our mission is to develop a superior vaccine platform to improve clinical outcomes for cancer patients
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $3.1M
- Funding stage: Seed
- Last round: Seed (Mar 2025)
- Website: irazuoncology.com
- Phone: 443-838-3002
Industries & Categories
Biopharma, Biotechnology, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/irazu-oncology-11108 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.